http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/ News About Tech, Money and Innovation Mon, 23 Nov 2009 13:10:15 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/comment-page-1/#comment-799301 Another medical-device startup tests the IPO waters » VentureBeat Tue, 18 Mar 2008 19:58:55 +0000 http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/#comment-799301 [...] given the generally awful climate for life-science IPOs and the fact that a similar startup — Transoma Medical — ended up withdrawing its IPO almost a month ago. Tags: co:CardioNet, IPO [...] [...] given the generally awful climate for life-science IPOs and the fact that a similar startup — Transoma Medical — ended up withdrawing its IPO almost a month ago. Tags: co:CardioNet, IPO [...]

]]> http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/comment-page-1/#comment-797741 Precision Thera merger with “blank check” Oracle Healthcare collapses » VentureBeat Wed, 05 Mar 2008 16:42:14 +0000 http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/#comment-797741 [...] first real sign the merger was in trouble came just about two weeks ago, when Oracle and Precision effectively cut the overall size of the deal by 15 percent — never a good sign. Oracle’s decision to walk away remains murky to me [...] [...] first real sign the merger was in trouble came just about two weeks ago, when Oracle and Precision effectively cut the overall size of the deal by 15 percent — never a good sign. Oracle’s decision to walk away remains murky to me [...]

]]> http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/comment-page-1/#comment-797732 Life sciences briefing: Wednesday, March 5, 2008 » VentureBeat Wed, 05 Mar 2008 15:25:53 +0000 http://venturebeat.com/2008/02/22/life-sciences-briefing-friday-feb-22-2008/#comment-797732 [...] first real sign the merger was in trouble came just about two weeks ago, when Oracle and Precision effectively cut the overall size of the deal by 15 percent — never a good sign. Oracle’s decision to walk away remains murky to me [...] [...] first real sign the merger was in trouble came just about two weeks ago, when Oracle and Precision effectively cut the overall size of the deal by 15 percent — never a good sign. Oracle’s decision to walk away remains murky to me [...]

]]>